Okyo Pharma executives buy shares on Nasdaq over two days in July 2026
The company's chief medical officer and chief executive both purchased ordinary shares on the open market within a day of each other.
SEC filing (2)
Latest
3 stories
Sign inSign in3 stories
The company's chief medical officer and chief executive both purchased ordinary shares on the open market within a day of each other.
SEC filing (2)